Rutten-van Mölken MP - Search Results

1

Current and future medical costs of asthma and chronic obstructive pulmonary disease in The Netherlands.

Rutten-van Mölken MP, Postma MJ, Joore MA, Van Genugten ML, Leidl R, Jager JC. Rutten-van Mölken MP, et al. Respir Med. 1999 Nov;93(11):779-87. doi: 10.1016/s0954-6111(99)90262-7. Respir Med. 1999. PMID: 10603626 Free article.

2

Costs and effects of inhaled corticosteroids and bronchodilators in asthma and chronic obstructive pulmonary disease.

Rutten-van Mölken MP, Van Doorslaer EK, Jansen MC, Kerstjens HA, Rutten FF. Rutten-van Mölken MP, et al. Am J Respir Crit Care Med. 1995 Apr;151(4):975-82. doi: 10.1164/ajrccm.151.4.7697275. Am J Respir Crit Care Med. 1995. PMID: 7697275 Clinical Trial.

3

Cognitive-educational treatment of fibromyalgia: a randomized clinical trial. II. Economic evaluation.

Goossens ME, Rutten-van Mölken MP, Leidl RM, Bos SG, Vlaeyen JW, Teeken-Gruben NJ. Goossens ME, et al. J Rheumatol. 1996 Jul;23(7):1246-54. J Rheumatol. 1996. PMID: 8823700 Clinical Trial.

4

Health economic assessment of behavioural rehabilitation in chronic low back pain: a randomised clinical trial.

Goossens ME, Rutten-Van Mölken MP, Kole-Snijders AM, Vlaeyen JW, Van Breukelen G, Leidl R. Goossens ME, et al. Health Econ. 1998 Feb;7(1):39-51. doi: 10.1002/(sici)1099-1050(199802)7:1<39::aid-hec323>3.0.co;2-s. Health Econ. 1998. PMID: 9541083 Clinical Trial.

5

The economic effects of screening for obstructive airway disease: an economic analysis of the DIMCA program.

van den Boom G, Rutten-van Mölken MP, Folgering H, van Weel C, van Schayck CP. van den Boom G, et al. Prev Med. 2000 Apr;30(4):302-8. doi: 10.1006/pmed.2000.0633. Prev Med. 2000. PMID: 10731459 Clinical Trial.

6

The treatment of newly diagnosed patients with glaucoma or with ocular hypertension in The Netherlands: an observational study of costs and initial treatment success based on retrospective chart review.

Oostenbrink JB, Rutten-van Mölken MP, Opdenoordt TS. Oostenbrink JB, et al. Doc Ophthalmol. 1999;98(3):285-99. doi: 10.1023/a:1002453604171. Doc Ophthalmol. 1999. PMID: 10945448

7

Resource use and costs of patients with glaucoma or ocular hypertension: a one-year study based on retrospective chart review in the Netherlands.

Oostenbrink JB, Rutten-van Mölken MP, Sluyter-Opdenoordt TS. Oostenbrink JB, et al. J Glaucoma. 2001 Jun;10(3):184-91. doi: 10.1097/00061198-200106000-00007. J Glaucoma. 2001. PMID: 11442180

8

The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands.

Feenstra TL, van Genugten ML, Hoogenveen RT, Wouters EF, Rutten-van Mölken MP. Feenstra TL, et al. Am J Respir Crit Care Med. 2001 Aug 15;164(4):590-6. doi: 10.1164/ajrccm.164.4.2003167. Am J Respir Crit Care Med. 2001. PMID: 11520721

9

The burden of asthma and chronic obstructive pulmonary disease: data from The Netherlands.

Rutten van-Mölken MP, Feenstra TL. Rutten van-Mölken MP, et al. Pharmacoeconomics. 2001;19 Suppl 2:1-6. doi: 10.2165/00019053-200119002-00001. Pharmacoeconomics. 2001. PMID: 11700783

10

The cost effectiveness of early treatment with fluticasone propionate 250 microg twice a day in subjects with obstructive airway disease. Results of the DIMCA program.

van den Boom G, Rutten-van Mölken MP, Molema J, Tirimanna PR, van Weel C, van Schayck CP. van den Boom G, et al. Am J Respir Crit Care Med. 2001 Dec 1;164(11):2057-66. doi: 10.1164/ajrccm.164.11.2003151. Am J Respir Crit Care Med. 2001. PMID: 11739135 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters